Coreg and Ototoxicity - a phase IV clinical study of FDA data
Ototoxicity is reported only by a few people who take Coreg.
The phase IV clinical study analyzes which people take Coreg and have Ototoxicity. It is created by eHealthMe based on reports of 44,673 people who have side effects while taking Coreg from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
44,673 people reported to have side effects when taking Coreg.
Among them, 2 people (0.0%) have Ototoxicity.
What is Coreg?
Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 46,012 Coreg users for its effectiveness, alternative drugs and more.
What is Ototoxicity?
Ototoxicity (damage to the ear) is found to be associated with 593 drugs and 325 conditions by eHealthMe.
Number of Coreg and Ototoxicity reports submitted per year:
Gender of people who have Ototoxicity when taking Coreg *:
- female: 100 %
- male: 0.0 %
Age of people who have Ototoxicity when taking Coreg *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 50 %
- 60+: 50 %
Common drugs people take besides Coreg *:
- Vioxx: 1 person, 50.00%
- Valtrex: 1 person, 50.00%
- Synthroid: 1 person, 50.00%
- Merrem: 1 person, 50.00%
- Imuran: 1 person, 50.00%
Common side effects people have besides Ototoxicity *:
- Ruptured Eardrum (tear in eardrum): 1 person, 50.00%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 50.00%
- Headache (pain in head): 1 person, 50.00%
- Dry Skin: 1 person, 50.00%
- Deafness Neurosensory: 1 person, 50.00%
- Constipation: 1 person, 50.00%
- Chronic Thyroiditis (long lasting inflammation of thyroid gland): 1 person, 50.00%
Common conditions people have *:
- Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 50.00%
- Ear Disorder: 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Coreg and have Ototoxicity?Check whether Ototoxicity is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
Alternative drugs to, pros and cons of Coreg:
- Coreg (46,012 reports)
Ototoxicity treatments and more:
- Ototoxicity (1,631 reports)
COVID vaccines that are related to Ototoxicity:
- Ototoxicity in Moderna COVID Vaccine
- Ototoxicity in Pfizer BioNTech Covid Vaccine
- Ototoxicity in Johnson and Johnson Covid Vaccine
How severe was Ototoxicity and when was it recovered:
Expand to all the drugs that have ingredients of carvedilol:
Common drugs associated with Ototoxicity:
All the drugs that are associated with Ototoxicity:
- Ototoxicity (593 drugs)
All the conditions that are associated with Ototoxicity:
- Ototoxicity (325 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on carvedilol (the active ingredients of Coreg) and Coreg (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.